Stocks making the biggest moves premarket: Sunrun, Verve Therapeutics, T-Mobile and more

Solar stocks declined sharply after the Senate's tax bill proposed phasing out renewable energy incentives, with Enphase Energy, First Solar, Sunrun, and SolarEdge Technologies dropping 20%, 16%, 36%, and 30%, respectively. Verve Therapeutics surged 77% after Eli Lilly agreed to acquire it for $10.50 per share, a 67.5% premium, while Roku gained 2% following an upgrade to buy from Loop Capital Markets and a price target increase to $100. Conversely, T-Mobile US fell 4.4% following reports that Softbank sold 21.5 million shares at $224 each.

Analysis

The pre-market session highlights significant volatility driven by legislative proposals, M&A activity, analyst revisions, and substantial share movements. Companies in the solar energy sector faced severe downturns, with Enphase Energy shares dropping 20%, First Solar and Sunrun sliding 16% and 36% respectively, and SolarEdge Technologies pulling back 30%, all attributed to the Senate's tax bill aiming to phase out renewable energy incentives. In contrast, Verve Therapeutics experienced a 77% premarket surge after Eli Lilly agreed to acquire the gene editing company for $10.50 per share, a 67.5% premium, in a deal valued at up to $1.3 billion expected to close in the third quarter; Eli Lilly's shares declined slightly. Roku shares gained 2% following an upgrade to a 'buy' rating from Loop Capital Markets, which also increased its price target to $100, implying a 22% upside, building on a 10% gain from the previous day after announcing an advertising partnership with Amazon. Microsoft shares fell nearly 1% amid reports by The Wall Street Journal of rising tensions with OpenAI over their AI partnership. Lennar, a homebuilder, saw its shares rise 2.5% after reporting stronger-than-expected fiscal second-quarter revenue of $8.38 billion, surpassing the FactSet consensus of $8.18 billion. T-Mobile US stock declined 4.4% following reports that Softbank sold 21.5 million shares in an unregistered, overnight transaction at $224 each, raising approximately $4.8 billion.

Key Decisions for Investors

• Investors should closely monitor the progression of the Senate's tax bill, as the proposed phase-out of renewable energy incentives presents a significant headwind to solar stocks such as Enphase Energy, First Solar, Sunrun, and SolarEdge Technologies.
• Verve Therapeutics shareholders should evaluate the considerable 67.5% acquisition premium offered by Eli Lilly, while Eli Lilly investors need to assess the strategic rationale and financial implications of the $1.3 billion deal.
• Roku's positive momentum, driven by an analyst upgrade and its Amazon partnership, warrants attention; however, investors should consider if the implied 22% upside to the new $100 price target adequately reflects its recent 10% rally and future growth prospects.
• The substantial Softbank share sale in T-Mobile US could create short-term selling pressure; investors should determine whether this signals a change in the company's fundamentals or is primarily a liquidity event driven by a major shareholder.
• Reported tensions between Microsoft and OpenAI regarding their AI partnership should be carefully watched, as the stability and success of this collaboration are important for Microsoft's AI strategy and market perception.